GPNMB and glioma: By employing GPNMB-specific scFv antibodies or immunotoxins, there was significant anti-tumor activity observed in GPNMB-expressing glioma and malignant melanoma cells in vitro as well as malignant glioma xenografts in mouse and melanoma neoplastic meningitis in vivo model (11).